Middle East and Africa Bronchiectasis Market - Industry Trends and Forecast to 2028

Segmentation

Short Description
Middle East and Africa Bronchiectasis Market, By Disease Type (CF Bronchiectasis and Non-CF Bronchiectasis), Severity (Mild to Moderate and Moderate-to-Severe), Type (Diagnosis and Treatment), Drugs Type (Branded and Generics), Route of Administration (Oral, Parenteral, and Inhalation), End User (Hospitals, Clinics, Home Health Care, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt  and Rest of Middle East and Africa) Industry Trends & Forecast to 2028           
Market Definition:
Bronchiectasis is a respiratory disorder which is characterized by permanent enlargement of the airways of lungs. It mainly occurs in women population with age group of 60 years and older. The symptoms for this disease are cough along with production of mucus with blood if the condition is worse, shortness of breath, chest pain nail clubbing, inflammation, chronic infections, and many others. It may also lead to other infections such as pneumonia, tuberculosis, week immune system and cystic fibrosis. People with kartageners syndrome, cystic fibrosis (CF) and primary ciliary dyskinesia (PCD) are at more risk to have bronchiectasis because these diseases are autosomal recessive inheritance disease. Therefore, it is very important to check the patients family history in order to avoid the bronchiectasis.

Market Segmentation:
Middle East and Africa bronchiectasis market is categorized into seven notable segments which are based on the basis of disease type, severity, type, drugs type, route of administration, end user, and distribution channel.
 On the basis of disease type, the Middle East and Africa bronchiectasis market is segmented into CF bronchiectasis and non-CF bronchiectasis.
 On the basis of severity, the Middle East and Africa bronchiectasis market is segmented into mild to moderate and moderate-to-severe.
 On the basis of type, the Middle East and Africa bronchiectasis market is segmented into diagnosis and treatment.
 On the basis of drugs type, the Middle East and Africa bronchiectasis market is segmented into branded and generic.
 On the basis of route of administration, the Middle East and Africa bronchiectasis market is segmented into oral, parenteral, and inhalation
 On the basis of end user, the Middle East and Africa bronchiectasis market is segmented into hospitals, clinics, home healthcare, and others
 On the basis of distribution channel, the Middle East and Africa bronchiectasis market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy and others
Market Players

The key market players for Middle East and Africa bronchiectasis market are listed below:

 Abbott
 HERSILL
 Inogen, Inc.
 Boehringer Ingelheim International GmbH
 Ache Laboratories Farmaceuticos S.A.
 Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)
 GlaxoSmithKline plc.
 AstraZeneca
 Pfizer Inc.
 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
 Novartis AG
 Sun Pharmaceutical Industries Ltd.
 Bayer AG
 Dr. Reddys Laboratories Ltd.
 Cipla Inc.

Methodology